EDWARDS LIFESCIENCES CARPENTIER-EDWARDS PERIMOUNT MAGNA MITRAL EASE PERICARDIAL BIOPROSTHESIS; REPLACEMENT, HEART-VALVE
|
Back to Search Results |
|
Model Number 7300TFX |
Device Problems
Calcified (1077); Gradient Increase (1270); Perivalvular Leak (1457); Insufficient Information (3190)
|
Patient Problems
Chest Pain (1776); Dyspnea (1816); Dizziness (2194); Insufficient Information (4580)
|
Event Date 02/14/2024 |
Event Type
Injury
|
Manufacturer Narrative
|
The subject device is not available for evaluation, as it remains implanted in the patient.The investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.Edwards will continue to review and monitor all reported events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
|
|
Event Description
|
It was reported that a patient with a 29mm 7300tfx mitral valve, implanted for six (6) years, nine (9) months, has been placed underwent evaluation for a valve-in-valve procedure due to unknown reason.
|
|
Event Description
|
It was reported that a patient with a 29mm 7300tfx mitral valve, implanted for six (6) years, nine (9) months, has been placed underwent evaluation for a valve-in-valve procedure due to calcification, severe mitral stenosis, and moderate perivalvular leak.The patient presented with shortness of breath, chest pain, and dizziness.A re-intervention is planned.
|
|
Event Description
|
It was reported that a patient with a 29mm 7300tfx mitral valve, implanted for six (6) years, nine (9) months, underwent a valve-in-valve procedure due to calcification, severe mitral stenosis and moderate perivalvular leak.The patient presented with shortness of breath, chest pain, and dizziness.The procedure was performed with a 29mm 9600tfx valve.
|
|
Manufacturer Narrative
|
H10: additional manufacturer narrative: updated sections: b2, b5, b7, d4 (expiration date), g3, g6, h2, h4, h6 (impact code, type of investigation, investigation findings, and investigation conclusions).The device history record (dhr) review was completed and there were two non-conformances found related to this serial number.However, the valve was re-worked to completion, passing all inspections.Calcific degeneration is a common cause of bioprosthetic heart valve failures.Many factors contribute to the onset and propagation of calcification.These include patient factors (age, disease state, pharmacological intervention, etc.), mechanical stress related to the valve's hemodynamic performance, and glutaraldehyde fixation of tissue.Of these, the fixation process is a relatively minor contributor to calcification for edwards' tissue valves due to anti-calcification treatments during manufacturing.Though numerous studies have been conducted on preventive calcification strategies in bioprosthetic heart valves, the causes of calcification are not fully understood and there are still no mechanisms or medical therapies which fully prevent bioprostheses from calcifying.Calcification is most commonly related to patient factors and is not usually an indication of a device malfunction related to a manufacturing deficiency.The instructions for use (ifu) have been reviewed and no inadequacies have been identified with regard to warnings, contraindications, and the directions/conditions for the successful use of the device.The reported type of event is included in the ifu.The most likely cause is patient factors, including a history of hyperlipidemia (hld).
|
|
Search Alerts/Recalls
|
|
|